English (UK)
中文版Justin Qin
Founded in 2019, Galixir aspires to be an engine to fuel up the whole pharmaceutical industry leveraging its world-leading AI technologies.
We have a team with solid background in both AI and pharmaceutical science. Our core team members come from MIT, Yale, Johns Hopkins, THU, PKU and other top universities, as well as leading pharma and tech companies.
We have a team with solid background in both AI and pharmaceutical science. Our core team members come from MIT, Yale, Johns Hopkins, THU, PKU and other top universities, as well as leading pharma and tech companies.
Galixir
Strategy and Business Development VPNatasha Qin
Curon biopharma is a clinical stage biopharmaceutical company focused on next generation anti-cancer therapies
Curon
BD DirectorRunxia Qiu
Sunland Capital is a leading venture capital firm focusing on healthcare.
Sunland Capital
Analyst
Fernando Salles
We are a clinical stage biopharma company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders
I-Mab Biopharma
SVP, Head of US and EU Business Developmentclaire Sha
Invest in healthcare and life science with focus on innovative technology.
AriMed Advisors Ltd
Partnerwei sha
Taifeng Group is a nationwide company, located in Henan province, focus on the medical industry in China. The company was established in 2005 and gradually formed a two-medicine model with both“Chinese and Western medicine research and development, manufacturing, and sales”. We developed a modern Taifeng Characteristic medicine system.
Henan Taifeng Medical Technology Group Co. LTD
vice presidentRocky Shao
HKEX list company，focusing on cardiovascular，biotechologic，ophthmalogic，oncologic，antibiotic and antivirus medicines and cardiovascular devices
China Grand Pharm
Executive DirectorScarlett Shen
Fosunpharma is a leading healthcare group in China. It has built a strong root domestically and developed a global operation strategy. With pharmaceutical manufacturing and R&D being core business segment, together with strong presences in medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail.
Responsive Web Design powered by 